![]() Scintillation well counter: too much activity? Monthly Scan. Technical artifacts in chromatographic analysis of Tc-99m radiopharmaceuticals. Technical parameters associated with miniaturized chromatographic systems. ![]() Taukulis RA, Zimmer AM, Pavel DG, Patel BA. New York, NY: Society of Nuclear Medicine 1984. Chromatography of Technetium-99m Radiopharmaceuticals: A Practical Guide. Quality control procedures for newer radiopharmaceuticals. Radiochemical purity of 99mTc-oxidronate. Ann Arbor, MI: Gelman Sciences 1977:3-56. Procedure Manual: Radiochemical Purity of Radiopharmaceuticals Using Gelman Seprachrom (ITLC) Chromatography. Albuquerque, NM: University of New Mexico College of Pharmacy 1980:69-80. Radiopharmacy Laboratory Manual for Nuclear Medicine Technologists. Rapid preparation and quality control of technetium-99m MAG3. Effect of solvent flow rate in mini-column testing of 99mTc-mertiatide. Maryland Heights, MO: Mallinckrodt Nuclear Medicine LLC 2013. A rapid radiochemical purity testing method for 99mTc-tetrofosmin. ![]() A better method of quality control for 99mTc-tetrofosmin. Rapid quality control for testing the radiochemical purity of 99mTc-tetrofosmin. Metayé T, Desmarquet M, Rosenberg T, Guilhot J, Bouin-Pineau MH. Arlington Heights, IL: GE Healthcare/Medi-Physic, Inc. A better method of quality control for technetium-99m sestamibi. Comparison of four alternative radiochemical purity testing methods for 99mTc-sestamibi. Rapid preparation and quality control method for technetium-99m-2-methoxy isobutyl isonitrile (technetium-99m-sestamibi). Hung JC, Wilson ME, Brown ML, Gibbons RJ. Billerica, MA: Lantheus Medical Imaging 2014. Optimal centrifugation parameters for labeling efficiency determination of technetium-99m labeled red blood cells. Maryland Heights, MO: Mallinckrodt Nuclear Medicine LLC 2015. Re: radiochemical purity of Tc-99m oxidronate. Radiochemical purity testing for 99mTc-exametazime: a comparison study for three-paper chromatography. Hung JC, Taggart TR, Wilson ME, Owens TP. Synthesis, characterization, and x-ray structural determinations of technetium(V)-oxo-tetradentate amine oxine complexes. Jurisson S, Schlemper EO, Troutner DE, Canning LR, Nowotnik DP, Neirinckx RD. Arlington Heights, IL: GE Healthcare/Medi-Physics, Inc. Crossref, Medline, Google Scholar,Ĭeretec. Deficiencies in product labeling instructions and quality control directions for 99mTc radiopharmaceuticals. Buroni FE, Lodola L, Persico MG, Aprile C. Deficiencies of product labeling directions for the preparation of radiopharmaceuticals. Radiochemical purity of routinely prepared 99Tc m radiopharmaceuticals: a retrospective study. Decristoforo C, Siller R, Chen F, Riccabona G. Technetium-99m radiopharmaceutical preparation problems: 12 years of experience. European system for reporting adverse reactions to and defects in radiopharmaceuticals: annual report 2001. European system for reporting adverse reactions to and defects in radiopharmaceuticals: annual report 2000. European system for reporting adverse reactions to and defects in radiopharmaceuticals: annual report 1999. European system for reporting adverse reactions to and defects in radiopharmaceuticals: annual report 1998. European system for reporting adverse reactions to and defects in radiopharmaceuticals: annual report 1997. European system for reporting adverse reactions to and defects in radiopharmaceuticals: annual report 1996. European system for reporting adverse reactions to and defects in radiopharmaceuticals: annual report 1995. ![]() Permissible molybdenum-99, strontium-82, and strontium-85 concentrations.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |